Search results for " trip"

showing 10 items of 535 documents

Effect of oral glutathione on hepatic glutathione levels in rats and mice

1989

Administration of oral glutathione (GSH) increases hepatic GSH levels in fasted rats, in mice treated with GSH depletors such as diethyl maleate and in mice treated with high doses of paracetamol. An increase in hepatic GSH levels after administration of oral GSH does not occur in animals treated with buthionine sulphoximine, an inhibitor of GSH synthesis. Administration of oral GSH leads to an increase in the concentration of l-cysteine, a precursor of GSH, in portal blood plasma. Oral administration of l-methionine produced a significant decrease of hepatic ATP in fasted rats, but not in fed rats. Administration ofN−acetylcysteine or GSH did not affect the hepatic ATP levels. The results …

medicine.medical_specialtyNecrosisRatónMedicine (miscellaneous)Micechemistry.chemical_compoundAdenosine TriphosphateMethionineBiosynthesisOral administrationInternal medicineHepatic glutathionemedicineAnimalsCysteineAcetaminophenchemistry.chemical_classificationNutrition and DieteticsChemistryMaleatesRats Inbred StrainsFastingGlutathioneGlutathioneAcetylcysteineRatsAmino acidEndocrinologyLiverMechanism of actionmedicine.symptomBritish Journal of Nutrition
researchProduct

Brain energy metabolism in global brain oedema.

1978

Different degrees of severity in global brain oedema were induced by varying amounts of water intoxication (50, 100, 150, and 200 ml Aqua dest./kg b.wt. intravenously) in groups of six cats, which were functionally nephrectomized. Animals loaded with physiological saline and sham-operated served as controls. Two hours following the water load, the tissue concentrations of CrP, ATP, ADP, AMP, pyruvate, glucose, and lactate were determined by optical enzymatic analysis. The results show disturbances in brain energy metabolism dependent on the severity of the brain oedema. The high energy compounds and in consequence the ATP/ADP-ratio, and respectively the energy charge potential, fall in dire…

medicine.medical_specialtyNeurologyBrain EdemaAdenosine TriphosphatemedicineAnimalsWater intoxicationPhysiological salineNeuroradiologyCATSmedicine.diagnostic_testBrain edemabusiness.industryWater IntoxicationBrainInterventional radiologymedicine.diseaseSurgeryAdenosine DiphosphateAnesthesiaCerebrovascular CirculationCatsSurgeryNeurology (clinical)NeurosurgerybusinessEnergy MetabolismActa neurochirurgica
researchProduct

A PRISMA-compliant systematic review of the endpoints employed to evaluate symptomatic treatments for primary headaches

2018

Abstract Background Primary headache are prevalent and debilitating disorders. Acute pain cessation is one of the key points in their treatment. Many drugs have been studied but the design of the trials is not usually homogeneous. Efficacy of the trial is determined depending on the selected primary endpoint and usually other different outcomes are measured. We aim to critically appraise which were the employed outcomes through a systematic review. Methods We conducted a systematic review of literature focusing on studies on primary headache evaluating acute relief of pain, following the PRISMA guideline. The study population included patients participating in a controlled study about sympt…

medicine.medical_specialtyNeurologyHeadache Disorders Primaryendpointspractice guidelines as topiclcsh:MedicineTriptansPlacebopatient complianceanti-inflammatory agentsnon-steroidal03 medical and health sciences0302 clinical medicineQuality of lifeInternal medicineprimarymedicineClinical endpoint030212 general & internal medicinehumansdisabled personsclinical trialsnon-steroidal anti-inflammatorybusiness.industryAnti-Inflammatory Agents Non-Steroidallcsh:RtryptaminesCorrectionacuteGeneral MedicineGuidelineacute; clinical trials; endpoints; non-steroidal anti-inflammatory; primary headaches; prisma-guidelines; triptans; anti-inflammatory agents non-steroidal; chronic disease; disabled persons; headache disorders primary; humans; patient compliance; practice guidelines as topic; treatment outcome; tryptamines; quality of lifemedicine.diseasetriptansClinical trialAnesthesiology and Pain Medicineheadache disordersMigrainequality of lifetreatment outcomeprimary headachesNeurology (clinical)prisma-guidelinesbusinesschronic disease030217 neurology & neurosurgeryResearch Articlemedicine.drug
researchProduct

Focal elevation of liver microsomal epoxide hydrolase in early preneoplastic stages and its behaviour in the further course of hepatocarcinogenesis.

1981

Abstract Treatment of rats with N-nitrosomorpholine (NNM) for 7 weeks led to a focal increase in liver microsomal epoxide hydrolase (EH) as early as 2 weeks after withdrawal of the carcinogen. This treatment also leads to hyperplastic nodules and liver tumors, but much later. At the same early time point, ATPase activity was decreased in the same islands. Most of these areas already had increased γ-glutamyltranspeptidase activity. The increase in EH at this early time point was more distinct than the decrease in ATPase which has thus far been considered a suitable marker of the earliest stages in hepatocarcinogenesis. The focal increase in EH was also observed in all benign hepatomas, but n…

medicine.medical_specialtyNitrosaminesATPaseBiophysicsBiochemistryLiver Neoplasms ExperimentalInternal medicinemedicineAtpase activityAnimalsMolecular BiologyCarcinogenAdenosine TriphosphatasesEpoxide HydrolasesbiologyLiver NeoplasmsCell Biologygamma-GlutamyltransferaseRatsEndocrinologyLiverMicrosomal epoxide hydrolasebiology.proteinMicrosomes LiverFemaleRabbitsHyperplastic nodulesPrecancerous ConditionsBiochemical and biophysical research communications
researchProduct

Metabolic changes in skeletal muscle of frog during exercise and recovery.

1991

medicine.medical_specialtyPhosphocreatineChemistryMusclesPhysical ExertionRana temporariaFructosephosphatesSkeletal muscleCreatineBiochemistryEndocrinologymedicine.anatomical_structureAdenosine TriphosphateInosine MonophosphateInternal medicinemedicineLactatesAnimalsEnergy MetabolismSwimmingBiochemical Society transactions
researchProduct

Clinical and Morphologic Predictors of Outcome in a Multicenter Cohort of ITP Patients Treated with Trombopoietin Analogues

2018

Abstract Background: The role of bone marrow response in patients with immune thrombocytopenia (ITP) has gained paramount importance since the last 10 years, with the demonstrations that marrow megakaryocytes (MGK) are unable to properly compensate platelets peripheral destruction. TPO receptor agonists (TPOa), namely romiplostim (ROMI) and eltrombopag (EPAG), by stimulating megakaryopoiesis are able to induce a response in 74% to 94% of cases in clinical trials. However, real world use of these drugs has shown frequent changes in individual dose requirement, the possibility of treatment discontinuation, and their effectiveness outside registered indications; moreover, nothing is known abou…

medicine.medical_specialtyRomiplostimbusiness.industryImmunologyEltrombopagAzathioprineCell BiologyHematologymedicine.diseaseBiochemistryInosine triphosphatechemistry.chemical_compoundchemistryDysplasiaInternal medicineCohortmedicineMiddle-aged adultbusinessAdverse effectmedicine.drugBlood
researchProduct

Oxygen and substrate deprivation on isolated rat cardiac myocytes : temporal relationship between electromechanical and biochemical consequences

1990

The effects of hypoxia and reoxygenation on action potentials (AP), contractions, and certain biochemical parameters were studied in isolated rat ventricular myocytes in monolayer culture in the presence and absence of glucose. Substrate deprivation alone had no influence on the basal properties. In the presence of glucose, a 4-h hypoxic treatment caused only a moderate decrease in AP amplitude and rate. In substrate-free conditions, hypoxia induced a gradual decline in plateau potential level and in AP duration and rate, followed by rhythm abnormalities and a failure of the electromechanical coupling. Spontaneous AP generation then ceased, and the resting potential decreased with increase…

medicine.medical_specialtyTime FactorsPhysiology[SDV]Life Sciences [q-bio]Action Potentialschemistry.chemical_element030204 cardiovascular system & hematologyBiologyGLYCOSEACIDE LACTIQUEOxygenMembrane PotentialsContractility03 medical and health sciencesAdenosine Triphosphate0302 clinical medicinePhysiology (medical)Internal medicinemedicineAnimalsMyocyteHypoxiaCells Cultured030304 developmental biologyPharmacologyFREQUENCE0303 health sciencesL-Lactate DehydrogenaseMyocardiumRats Inbred StrainsBiological activityGeneral MedicineHypoxia (medical)Myocardial ContractionRatsElectrophysiologyATP[SDV] Life Sciences [q-bio]ElectrophysiologyGlucoseEndocrinologychemistryCell cultureCirculatory systemLactatesBiophysicsRATmedicine.symptom
researchProduct

Optimization of the Speech Test Material in a Group of Hearing Impaired Subjects: A Feasibility Study for Multilingual Digit Triplet Test Development

2021

Background: The development of the global digit-in-noise test requires optimization of each language version on a group of normal-hearing native-speakers. An alternative solution may be an adaptive optimization during ongoing tests in a group of subjects with unknown hearing impairments. The objective of the research was to compare the optimization results between these groups. Methods: Digit triplets consisting of three pseudo-randomly selected digits were presented in speech-shaped noise at various signal-to-noise ratios (SNRs), according to the protocol of the final speech test. Digit-specific and position-specific speech reception thresholds (SRTs) were determined and compared between g…

medicine.medical_specialtyspeech audiometry; speech intelligibility in noise; digit triplet test; digit-in-noise test; speech reception threshold; tele-audiology; mobile-based hearing testsdigit-in-noise testspeech audiometryAudiologyArticle03 medical and health sciences0302 clinical medicineTest materialotorhinolaryngologic diseasesmedicinemobile-based hearing tests030212 general & internal medicineSpeech reception030223 otorhinolaryngologydigit triplet testGroup (mathematics)tele-audiologyspeech reception thresholdNumerical digitTest (assessment)Continuous noiseNoiseRF1-547OtorhinolaryngologyHearing impairedspeech intelligibility in noisePsychologyAudiology Research
researchProduct

Viaggi multi-destinazione in Sicilia: principali determinanti ed effetti distorcenti nelle statistiche sul turismo

2013

multi-destination tripconsumer behavioursSettore SECS-S/05 - Statistica Socialetourism statistic
researchProduct

Neridronate prevents bone loss in patients receiving androgen deprivation therapy for prostate cancer.

2004

Today, androgen deprivation therapy is a cornerstone of treatment for advanced prostate cancer, although it presents important complications such as osteoporosis. Neridronate, a relatively new bisphosphonate, is able to prevent bone loss in patients with prostate cancer during androgen ablation. Introduction: Androgen-deprivation therapy (ADT) is a cornerstone of treatment for advanced prostate cancer. This therapy has iatrogenic complications, such as osteoporosis. The aim of our study was to evaluate the efficacy of neridronate, a relatively new bisphosphonate, to prevent bone loss during androgen ablation. Materials and Methods: Forty-eight osteoporotic patients with prostate cancer, tre…

musculoskeletal diseasesMalemedicine.medical_specialtyDeoxypyridinolineTime FactorsBicalutamideAntineoplastic Agents HormonalEndocrinology Diabetes and Metabolismmedicine.medical_treatmentOsteoporosisUrologyBone and BonesAndrogen deprivation therapychemistry.chemical_compoundProstate cancerAbsorptiometry PhotonBone DensityMedicineNeridronic acidHumansOrthopedics and Sports MedicineAmino AcidsAgedCholecalciferolTriptorelin PamoateDiphosphonatesbusiness.industryProstatic NeoplasmsAndrogen AntagonistsBisphosphonatemedicine.diseaseAlkaline PhosphataseAndrogen deprivation therapy; Bisphosphonates; Neridronate; Osteoporosis; Prostate cancer; Absorptiometry Photon; Aged; Alkaline Phosphatase; Amino Acids; Androgen Antagonists; Androgens; Antineoplastic Agents Hormonal; Bone Density; Bone and Bones; Calcium; Cholecalciferol; Diphosphonates; Humans; Male; Osteoporosis; Prostatic Neoplasms; Time Factors; Triptorelin Pamoate; SurgerySurgerychemistryAndrogensOsteoporosisCalciumbusinessCholecalciferolmedicine.drugJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
researchProduct